We are live on
!
Find out more
HA
HC Advisors Portfolio holdings
AUM
$149M
1-Year Est. Return
17.72%
This Fund
S&P 500
This Quarter
Est. Return
-2.87%
1 Year Est. Return
+17.72%
3 Year Est. Return
+55.19%
5 Year Est. Return
+59.33%
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$4.14M
(-2.4%)
Cap. Flow
+$1.54M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
57%
Holding
88
New
5
Increased
38
Reduced
22
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.81M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$637K |
| 3 |
Grindr
GRND
|
+$570K |
| 4 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$391K |
| 5 |
Chevron
CVX
|
+$236K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$655K |
| 2 |
Schwab US TIPS ETF
SCHP
|
+$579K |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$542K |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$303K |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$285K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.2% |
| 2 | Healthcare | 2.42% |
| 3 | Industrials | 1.67% |
| 4 | Consumer Discretionary | 1.14% |
| 5 | Financials | 1.05% |
Similar funds
ZC
LGM
SWM
AWF
AIA
TWM
E
GWA
HC Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, HC Advisors held 88 positions worth $168M, down 2.4% from $172M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
HC Advisors's Q3 2023 filing shows 5 new, 38 increased, 22 reduced and 5 closed positions. Its largest new stake was iShares Asia/Pacific Dividend ETF: 6,680 shares worth $214K. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $655K.
By sector, the portfolio is most concentrated in Technology at 4.2% of assets, up from 4.1% a quarter earlier, followed by Healthcare and Industrials.
- HC Advisors's largest Q3 2023 buy was iShares Asia/Pacific Dividend ETF: 6,680 shares worth $214K.
- HC Advisors added most to Schwab Intermediately-Term US Treasury ETF in Q3 2023, an estimated $1.81M increase.
- HC Advisors's biggest Q3 2023 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $655K.
- HC Advisors fully exited Apellis Pharmaceuticals in Q3 2023, selling an estimated $285K.
- HC Advisors's ten largest holdings make up 57% of its $168M portfolio in Q3 2023.
- HC Advisors opened 5 new positions and closed 5 in Q3 2023.
- HC Advisors's portfolio value fell 2.4% quarter-over-quarter to $168M.
Based on HC Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.